Macrophage modulation to reduce disease progression in hospitalized patients with COVID-19

N=209 Seriously ill patients with COVID-19 require ICU care, and have high rates of mortality, especially amongst patients with concurrent diseases such as high blood pressure. Recent clinical data demonstrate that disease progression is associated with an overwhelming, atypical cytokine response known as “Macrophage Activation Syndrome” (MAS). Macrophages are immune cells that can directly damage […]

Read More